Results 151 to 160 of about 6,979 (199)

Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases. [PDF]

World J Surg Oncol
Chen J, Cao D.
europepmc   +1 more source

Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report. [PDF]

Mol Clin Oncol
Ueda M, Watanabe T, Momma T, Kanke Y, Kato A, Okabe C, Sato T, Kamo N, Endo Y, Furukawa S, Soeda S, Fujimori K.   +11 more
europepmc   +1 more source

Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis. [PDF]

Front Oncol
Cui J, Zhao YC, She LZ, Wang TJ.
europepmc   +1 more source

Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan. [PDF]

J Gynecol Oncol
Choi CH, Lee YY, Lai YL, Chang K, Kim HS, Chen J, Chen YL.   +6 more
europepmc   +1 more source

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia. [PDF]

J Gynecol Oncol
Lv X, Guo L, Wang C.
europepmc   +1 more source

End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer. [PDF]

J Med Imaging (Bellingham)
Kahaki S, Hagemann IS, Cha KH, Trindade C, Petrick N, Kostelecky N, Borden LE, Atwi D, Fung KM, Chen W.   +9 more
europepmc   +1 more source

Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. [PDF]

J Gynecol Oncol
Li X, Wang Y, Wang J, Zhou J, Wang J.
europepmc   +1 more source

Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study

, 2015
Amelia Jernigan, Kathryn A. Maurer, Karen Cooper, Philip R. Schauer, Peter S. Rose, Chad M. Michener   +5 more
openalex   +1 more source

Supplementary Table S3 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

Mikayla B. Bowen, Brenda Melendez, Qian Zhang, Richard K. Yang, Bryan Fellman, Barrett C. Lawson, Naomi Adjei, Joseph Celestino, Khalida Wani, Bhavana Singh, Diana L. Urbauer, Alexander J. Lazar, Karen H. Lu, Jennifer A. Wargo, Shannon N. Westin, Melinda S. Yates   +15 more
openalex   +1 more source